Much of Chris’ practice involves working closely with SMEs, often born out of promising academic research by major UK universities, helping them to develop effective intellectual property strategies and secure multi-million pound investments. He also works with in-house patent attorneys and senior executives at major multinationals, and has expertise in worldwide patent prosecution.
Chris has particular experience in relation to fuel cell technologies, mobile phone antennas, metal coatings, oil and gas exploration, medical devices, civil engineering, electronic article surveillance and endoscopy.
After taking his first degree in natural sciences and a postgraduate diploma in computer science at Christ’s College Cambridge, Chris entered the profession directly in 1991, training with a large private practice firm in London. He qualified in 1995, and joined HGF as a partner in 1999.
Chris is fluent in German, and is experienced in acting before the Opposition and Appeal Divisions of the European Patent Office in Munich.
Chris heads the Engineering team in HGF's Leeds office, and serves as Chair of HGF's Conflicts Committee.
Natural Sciences (Cantab)
Postgraduate Diploma in Computer Science (Cantab)
Postgraduate Certificate in Intellectual Property Law (London)
Intellectual Property Litigation Certificate
Chris regularly leads tutorials, both in-house and externally, for trainee patent attorneys preparing for UK and European qualifying examinations.
Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …Read article
Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …Read article
The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …Read article
Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …Read article
Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …Read article
To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …Read article
HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.